Showing 1 - 10 of 16
Pot comparisons
Oped, Postbag, Published on 13/01/2023
» Re: "Look at developed nations like the US, Singapore," (InQuote, Jan 12).
Managing Covid drugs
Oped, Editorial, Published on 01/04/2022
» Record Covid cases and ongoing reports of sluggish management of Covid medicine stock might derail the government's ambitious plans to list Covid-19 as endemic on July 1.
Test kit snags worsen
Oped, Editorial, Published on 20/01/2022
» The threat posed by the highly transmissible Omicron coronavirus variant makes rapid testing more than necessary. Yet the high prices of test kits and shortage of supply have made containing the pandemic that much harder.
New test kit mystery
Oped, Editorial, Published on 08/10/2021
» Antigen test kits (ATK), used in detection of the coronavirus, are now more than just a medical device; they are also the latest strategic tool for reopening business and activities.
GPO must act fast on ATKs
Oped, Editorial, Published on 25/08/2021
» The cabinet motion yesterday on the problematic procurement of home-use rapid antigen test kits (ATKs) proves one thing. The prime minister -- who has crafted thirty articles of legislation relating to Covid with his own hands since March -- cannot use his power and leadership to defuse the conflict that has erupted at a time when society needs his guidance the most.
Testing question
Oped, Postbag, Published on 21/08/2021
» Re: "Cabinet approves medic immunity bill," (BP, Aug 18).
Sinovac makes sense
Oped, Postbag, Published on 20/08/2021
» Re: "Why more Sinovac?," (Editorial, Aug 18).
Covid self-test kit woes
Oped, Editorial, Published on 13/08/2021
» The Ministry of Public Health has made the right move with its policy of providing 8.5 million free Covid antigen self-testing kits to the public. The kits offer some hope for efforts to contain the pandemic. They will enable early detection and timely treatment -- keys to reducing serious illness while protecting the healthcare system from collapsing.
Act now on favipiravir
Oped, Editorial, Published on 04/08/2021
» Access to medicine can make a life-and-death difference amid the Covid-19 emergency. The government cannot afford to fail in the crucial mission of securing enough of the antiviral medication favipiravir to cover the rapid increase of patients.
A failure to communicate
Oped, Editorial, Published on 17/07/2021
» In a time when society needs unity to overcome the pandemic, it's dispiriting to see the Governmental Pharmaceutical Organization (GPO) filing a libel lawsuit against Thonburi Healthcare Group (THG) chairman Boon Vanasin, who recently voiced his frustration about the slow pace of vaccine imports, a reaction related to his group's vaccine procurement having to go through state agencies.